The Maldivian government has granted an emergency approval for the use of the Pfizer BioNTech vaccine and the Sinopharm vaccine for COVID-19.
Approval for the vaccines was granted yesterday by the Maldivian Food and Drug Authority (MFDA).
Sinopharm is developed by a Chinese company and will be administered to those aged between 18 to 16. Meanwhile, Pfizer-BioNTech is widely regarded as the most effective vaccine currently available.
Maldives has vaccinated 46% of its eligible population since the mass vaccination program began on February 1st. Maldives is set receive more vaccine doses from India.